P032-2694 Screening compound: N-[(2,4-difluorophenyl)methyl]-2-[7-(4-methoxyphenyl)-5-methyl-3-oxo-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl]acetamide

P032-2694 Screening compound: N-[(2,4-difluorophenyl)methyl]-2-[7-(4-methoxyphenyl)-5-methyl-3-oxo-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl]acetamide
P032-2694 Screening compound: N-[(2,4-difluorophenyl)methyl]-2-[7-(4-methoxyphenyl)-5-methyl-3-oxo-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P032-2694
N-[(2,4-difluorophenyl)methyl]-2-[7-(4-methoxyphenyl)-5-methyl-3-oxo-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P032-2694

Molecular Formula

C22H19F2N5O3 (C22 H19 F2 N5 O3)

Compound Name

N-[(2,4-difluorophenyl)methyl]-2-[7-(4-methoxyphenyl)-5-methyl-3-oxo-2H,3H-[1,2,4]triazolo[4,3-c]pyrimidin-2-yl]acetamide

IUPAC name

N-[(24-difluorophenyl)methyl]-2-[7-(4-methoxyphenyl)-5-methyl-3-oxo-2H3H-[124]triazolo[43-c]pyrimidin-2-yl]acetamide

SMILES

CC(N12)=NC(c(cc3)ccc3OC)=CC2=NN(CC(NCc(ccc(F)c2)c2F)=O)C1=O

InChI

InChI=1S/C22H19F2N5O3/c1-13-26-19(14-4-7-17(32-2)8-5-14)10-20-27-28(22(31)29(13)20)12-21(30)25-11-15-3-6-16(23)9-18(15)24/h3-10H,11-12H2,1-2H3,(H,25,30)

InChI Key

LGNGBMXNBUGWEM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD20734964

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

439.42

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.013

Distribution Coefficient, logD

3.005

Water Solubility, LogSw

-3.38

Polar Surface Area

73.005

Acid Dissociation Constant (pKa)

13.40

Base Dissociation Constant (pKb)

5.67

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

18.20

P032-2694 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

SmartTM Library (51161 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P032-2694 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P032-2694?
Check Price and Availability of P032-2694, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P032-2694 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P032-2694
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P032-2694
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P032-2694 available by request